Lumos Pharma, Inc. - Common Stock (LUMO)
4.3400
0.00 (0.00%)
Lumos Pharma Inc is a biotechnology company focused on developing innovative therapies for rare genetic diseases
The company specializes in creating treatments that target underlying biological mechanisms, aiming to improve patient outcomes through its proprietary drug development pipeline. Through a strong commitment to research and development, Lumos Pharma seeks to address unmet medical needs and enhance the quality of life for individuals affected by these rare conditions. Its dedicated team collaborates with healthcare professionals and advocates to advance its mission of providing effective and accessible treatments.
Frequently Asked Questions
Is Lumos Pharma, Inc. - Common Stock publicly traded?
Yes, Lumos Pharma, Inc. - Common Stock is publicly traded.
What exchange does Lumos Pharma, Inc. - Common Stock trade on?
Lumos Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lumos Pharma, Inc. - Common Stock?
The ticker symbol for Lumos Pharma, Inc. - Common Stock is LUMO on the Nasdaq Stock Market
What is the current price of Lumos Pharma, Inc. - Common Stock?
The current price of Lumos Pharma, Inc. - Common Stock is 4.340
When was Lumos Pharma, Inc. - Common Stock last traded?
The last trade of Lumos Pharma, Inc. - Common Stock was at 4:00 pm EST on December 11th, 2024
What is the market capitalization of Lumos Pharma, Inc. - Common Stock?
The market capitalization of Lumos Pharma, Inc. - Common Stock is 36.27M
How many shares of Lumos Pharma, Inc. - Common Stock are outstanding?
Lumos Pharma, Inc. - Common Stock has 8.36M shares outstanding.